Table 2 Univariate and multivariate... | American Society of Hematology

Table 2

Univariate and multivariate analysis of relapse, DFS, and OS (N = 132)

Parameter	Univariate analysis			Multivariate analysis
Parameter	HR	95% CI	P	HR	95% CI	P
Relapse
HRD-HSCT vs chemotherapy	0.14	0.11-0.36	< .001	0.096	0.036-0.26	< .001
WBC count > 50 vs ≤ 50	1.87	102-4.57	.043	1.006	1.002-1.009	.004
Age > 40 y vs ≤ 40 y	2.01	1.13-3.69	.017			NS
No. of courses to CR 2-3 vs 1	2.26	1.35-4.84	.004			NS
DFS
HRD-HSCT vs chemotherapy	0.32	0.19-0.55	< .001	0.28	0.12-0.63	.002
WBC count > 50 vs ≤ 50	1.24	0.65-2.51	.49	1.004	1.000-1.008	.03
Age > 40 y vs ≤ 40 y	1.83	1.08-3.24	.026			NS
No. of courses to CR 2-3 vs 1	1.76	1.05-3.45	.035			NS
OS
HRD-HSCT vs chemotherapy	0.32	0.18-0.65	.001	0.44	0.19-0.99	.047
WBC count > 50 vs ≤ 50	1.54	0.75-3.63	.21			NS
Age > 40 y vs ≤ 40 y	2.18	1.17-4.11	.014			NS
No. of courses to CR 2-3 vs 1	1.58	0.84-3.23	.15			NS

Parameter	Univariate analysis			Multivariate analysis
Parameter	HR	95% CI	P	HR	95% CI	P
Relapse
HRD-HSCT vs chemotherapy	0.14	0.11-0.36	< .001	0.096	0.036-0.26	< .001
WBC count > 50 vs ≤ 50	1.87	102-4.57	.043	1.006	1.002-1.009	.004
Age > 40 y vs ≤ 40 y	2.01	1.13-3.69	.017			NS
No. of courses to CR 2-3 vs 1	2.26	1.35-4.84	.004			NS
DFS
HRD-HSCT vs chemotherapy	0.32	0.19-0.55	< .001	0.28	0.12-0.63	.002
WBC count > 50 vs ≤ 50	1.24	0.65-2.51	.49	1.004	1.000-1.008	.03
Age > 40 y vs ≤ 40 y	1.83	1.08-3.24	.026			NS
No. of courses to CR 2-3 vs 1	1.76	1.05-3.45	.035			NS
OS
HRD-HSCT vs chemotherapy	0.32	0.18-0.65	.001	0.44	0.19-0.99	.047
WBC count > 50 vs ≤ 50	1.54	0.75-3.63	.21			NS
Age > 40 y vs ≤ 40 y	2.18	1.17-4.11	.014			NS
No. of courses to CR 2-3 vs 1	1.58	0.84-3.23	.15			NS

NS indicates no significance.